VDJ

VDJ engages in the R&D of monoclonal antibody drugs.

Number of Funding Rounds

Total Funding Amount

4

¥56M

VDJ has raised a total of ¥56M in funding over 2 rounds. Their latest funding was raised on Jul 3, 2018 from a Series C round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jul 3, 2018	Series C	¥30M	1	Beijing Youhe Dingxin Equity Investment Management	—	Detail
Dec 13, 2017	Series B	¥20M	1	Beijing Hankang Chuangye Touzi	—	Detail
Sep 30, 2016	Series A	¥3M	1	—	—	Detail
Jun 4, 2014	Angel	¥3M	1	—	—	Detail

Number of Lead Investors

Number of Investors

2

4

VDJ is funded by 4 investors. Beijing Youhe Dingxin Equity Investment Management and Beijing Hankang Chuangye Touzi are the most recent investors.

Investor Name	Lead Investor	Funding Round
Beijing Youhe Dingxin Equity Investment Management	Yes	Series C
Beijing Hankang Chuangye Touzi	Yes	Series B
Beijing Yinglida Biological Technology	—	Series A
KMT Technology	—	Angel